BCLI insider trading
BRAINSTORM CELL THERAPEUTICS INC. — open-market insider buys and $1M+ sells from SEC Forms 3, 4 and 5.
Buys · last 90 days
0 · $0
Most recent buy
2024-10-02
Recent insider filings
| Filed | Insider | Type | Shares | Price | Value |
|---|
| 2024-10-02 | Lebovits Chaim President & CEO | Bought | 23,836 | $0.48 | $11k |
Most active insider buyers
| Insider | Role | Buys | Total bought |
|---|
| Lebovits Chaim | President & CEO | 1 | $11k |
See BCLI on the chart
Every insider buy and sell for BCLI plotted on the price, the full two-year history, cluster scores and daily updates — in the members area, $29/month. A free quarterly sample of the whole dataset needs no account.
Open the browserFree sampleData from the SEC EDGAR ownership filings, refreshed daily. Only open-market purchases (transaction code P) and sales of $1M or more are shown; grants, option exercises and tax withholding are excluded because they run on schedules set years earlier. Not investment advice.